Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 4.1
edited by Evdokimos Konstantinidis
on 2021/12/08 12:15
Change comment: There is no comment for this version
To version 6.1
edited by Sarantis Dimitriadis
on 2023/05/30 09:33
Change comment: There is no comment for this version

Summary

Details

Page properties
Author
... ... @@ -1,1 +1,1 @@
1 -XWiki.evdokimosk
1 +XWiki.Sarantis
Content
... ... @@ -1,3 +1,189 @@
1 +(% class="western" lang="en-GB" style="text-align:justify" %)
2 +(% lang="en-US" %)**End user:** A person who ultimately uses or is intended to ultimately use the product, service or process. In living lab project, end user is defined as a primary study participant who voluntarily participates research after giving informed consent to be the subject of the research.
3 +
4 +(% class="western" lang="en-GB" style="text-align:justify" %)
5 +(% lang="en-US" %)**Living lab research infrastructure end user:** A person or organization who(%%) (% lang="en-US" %)purchases or uses living lab research infrastructure services to conduct a specific contract based research and development activity (often focusing on specifically defined end user group). Living lab research infrastructure end user can also be study participant (a.k.a. end user), if living project is focusing on developing living lab services and infrastructure.
6 +
7 +(% class="western" lang="en-GB" style="text-align:justify" %)
8 +(% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following:
9 +
10 +:
11 +
12 +* (((
13 +(% lang="en-US" %)**Non-professional end users:**
14 +
15 +* (% lang="en-US" %)**Consumers: **Those who buy goods or services for their own use.
16 +
17 +* (% lang="en-US" %)**Public health and social service clients: **Those who use public services.
18 +)))
19 +
20 +:
21 +
22 +* (((
23 +(% lang="en-US" %)**Professional end users**
24 +
25 +* (% lang="en-US" %)**Health professionals and managers:** A person providing health care treatment and advice based on formal training and experience. Also known as healthcare professional or healthcare worker.
26 +
27 +* (% lang="en-US" %)**Social care workers and managers:** Those providing the practical support to help people cope with the day-to-day business of living based on formal training and experience.
28 +
29 +* (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level.
30 +)))
31 +
32 +:
33 +
34 +(% class="western" lang="en-GB" %)
35 +(% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows:
36 +
37 +:
38 +
39 +* (((
40 +(% lang="en-US" %)**Private sector organizations: **(business developers and researchers)
41 +
42 +* (% lang="en-US" %)Tangible equipment and device manufactures
43 +
44 +* (% lang="en-US" %)Health and social service providers
45 +
46 +* (% lang="en-US" %)e-health, IT system and digital technology providers
47 +
48 +* (% lang="en-US" %)Wellbeing and wellness service providers
49 +
50 +* (% lang="en-US" %)Pharmaceutical companies
51 +)))
52 +
53 +:
54 +
55 +* (((
56 +(% lang="en-GB" %)
57 +(% lang="en-US" %)**Public sector organizations:**
58 +
59 +* (% lang="en-US" %)**Local level: **Municipals, cities and other local level public organizations providing e.g. health and social services such as primary health care.
60 +
61 +* (% lang="en-US" %)**Regional level: **e.g.** **Regional** **hospitals providing secondary and tertiary care,** **councils, parliaments, and governments as well as other administrative organizations operating at regional level.
62 +
63 +* (% lang="en-US" %)**National level: **Government agencies, departments or temporary pointed working groups responsible for the specific functions such as health and social services.
64 +
65 +* (% lang="en-US" %)**International level: **European commission departments and agencies as well as other organizations operating at international and transnational level.
66 +
67 +* (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process.
68 +)))
69 +
70 +:
71 +
72 +* (((
73 +(% lang="en-GB" %)
74 +(% lang="en-US" %)**Education and research organizations:**
75 +
76 +* (% lang="en-US" %)**Higher education institutes:** Universities and Universities of Applied Sciences
77 +
78 +* (% lang="en-US" %)**Other educational institutes** covering early childhood, primary, secondary and tertiary education
79 +
80 +* (% lang="en-US" %)**Public research institutions/organizations** such as technical research centers and government laboratories.
81 +
82 +* (% lang="en-US" %)**Private research organizations** such as technology and innovation centers
83 +)))
84 +
85 +:
86 +
87 +* (((
88 +(% lang="en-GB" %)
89 +(% lang="en-US" %)**Civil society organizations:**
90 +
91 +* (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level.
92 +)))
93 +
94 +:
95 +
96 +* (((
97 +(% lang="en-GB" %)
98 +(% lang="en-US" %)**Networks and clusters:**
99 +
100 +* (% lang="en-US" %)Company cluster organizations and company networks
101 +* (% lang="en-US" %)International, national, regional and local networks
102 +)))
103 +
104 +:
105 +
106 +(% class="western" lang="en-GB" %)
107 +(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in the following table .
108 +
109 +(% style="height:1004px; margin-left:auto; margin-right:auto; width:1694px" %)
110 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups**
111 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
112 +(% lang="en-US" %)Specific age range
113 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
114 +
115 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
116 +(% class="western" %)
117 +
118 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)(((
119 +(% class="western" %)
120 +
121 +)))
122 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)General Population
123 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
124 +(% class="western" %)
125 +
126 +)))
127 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)**
128 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
129 +(% class="western" lang="en-GB" %)
130 +(% lang="en-US" %)Healthy
131 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
132 +(% class="western" lang="en-GB" %)
133 +
134 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
135 +(% class="western" lang="en-GB" %)
136 +
137 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
138 +(% class="western" lang="en-GB" %)
139 +
140 +)))
141 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
142 +(% class="western" %)
143 +
144 +)))
145 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)**
146 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Schizophrenia|Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Parkinson Disease
147 +|Post-Stroke Patients with Moving or Linguistic Disability|Mild Cognitive Impairment|Sleep Disorders: e.g., Apnea, Hypopnea|With Disability
148 +|Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)
149 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
150 +(% class="western" %)
151 +
152 +)))
153 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)**
154 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Parkinson Disease|Mild Cognitive Impairment|With Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
155 +(% class="western" %)
156 +
157 +)))
158 +|Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
159 +(% class="western" lang="en-GB" %)
160 +
161 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
162 +(% class="western" lang="en-GB" %)
163 +
164 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
165 +(% class="western" lang="en-GB" %)
166 +
167 +)))
168 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
169 +(% class="western" %)
170 +
171 +)))
172 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)**
173 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
174 +(% class="western" lang="en-GB" %)
175 +Down Syndrome
176 +)))
177 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Chronical Diseases: e.g., Persons With Chronic Pulmonary (Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Cardiological Or Other Conditions (Aphasia)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
178 +(% class="western" lang="en-GB" %)
179 +
180 +)))
181 +
182 +:
183 +
184 +(% class="western" lang="en-GB" %)
185 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) .
186 +
1 1  |**Researcher expertise**|**Brief use case description**
2 2  |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making
3 3  |Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)
XWiki.XWikiComments[0]
Comment
... ... @@ -1,0 +1,5 @@
1 +I think in general, the title 'Customer segments' is confusing. When I think customers of living lab methodologies, I think about businesses, healthcare organizations, public authorities, universities... and not about the researchers.
2 +
3 +Shouldn't the title rather be 'Research fields for H&W Living Labs'?
4 +
5 +Also, for the same reason, I do not understand the link with the title 'Living Lab Business model'. Not the researchers but the actual users of the living lab activities (cf. above) are crucial in the business model, as they (should) pay for the living lab services and gain interest and insights from them)
Date
... ... @@ -1,0 +1,1 @@
1 +2022-01-10 15:43:06.877
Selection
... ... @@ -1,0 +1,1 @@
1 +Researcher expertise
State
... ... @@ -1,0 +1,1 @@
1 +SAFE
Target
... ... @@ -1,0 +1,1 @@
1 +Living Lab Business Model.Customer segments in Health and Wellbeing Living Labs.WebHome

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project